| Application no. and date | 08784834.7 (espacenet) (Federated) (European Patent Register), 20080717 | | Patent/reg. no. and date | DK/EP 2167128, 20121024 | | Publication date | 20100331 | | Priority no. and date | EP 07013964, 20070717 | | EP pub. no. and date |
EP 2167128 20100331 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | P50593DK01 | | Inventor | LO, Kin-Ming, 6 Carol Lane
Lexington, MA 02420, US,
ADAN, Jaume, Pujol, 28
E-08310 Mataro, ES,
MITJANS, Francesc, Pujadas 78, 42a
E-08700 Igualada, ES,
GOODMAN, Simon, Hahlgartenstrasse 29
64347 Griesheim, DE,
HAHN, Diane, Im Berggarten 2
64342 Seeheim-Jugenheim, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | FREMSTILLEDE ANTI-ALFA-V-INTEGRIN HYBRID-ANTISTOFFER | | Int. application no. | EP2008005852 | | Int. publication no. | WO2009010290 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
